TitleGenColors Logo

Gene list

Applied filters:

COG category: Defense mechanisms
Organism: Neisseria meningitidis Z2491, Z2491
Gene type: CDS

Number of genes found: 19

Free access
Sort by:

 



# Neisseria meningitidis Z2491, Z2491

>gid:333764  NMA0535  putative ABC transporter ATP-binding protein
MIEKLTFGLFKKEDARSFMRLMAYVRPYKIRIVAALIAIFGVAATESYLA
AFIAPLINHGFSAPAAPPELSAAAGILSTLQNWREQFTYMVWGTENKIWT
VPLFLIILVVIRGICRFTSTYLMTWVSVMTISKIRKDMFAKMLTLSSRYH
QETPSGTVLMNMLNLTEQSVSNASDIFTVLTRDTMIVTGLTIVLLYLNWQ
LSLIVVLMFPLLSLLSRYYRDRLKHVISDSQKSIGTMNNVIAETHQGHRV
VKLFNGQAQAANRFDAINRTIVRLSKKITQATAAHSPFSELIASIALAVV
IFIALWQSQNGYTTIGEFMAFIVAMLQMYAPIKSLANISIPMQTMFLAAD
GVCAFLDTPPEQDKGTLAPQRVEGRISFRNVDVEYRSDGIKALDGFNLDI
RQGERVALVGRSGSGKSTVVNLLPRFVEPSAGNICIDGIDIADIKLDCLR
AQFALVSQDVFLFDDTLFENVRYSRPDAGEAEVLSALQAANLQSLIDASP
LGLHQPIGSNGSNLSGGQRQRVAIARAILKDAPILLLDEATSALDNESER
LVQQALERLMENRTGIIVAHRLTTIEGADRIIVMDDGKIIEQGTHEQLMS
QNGYYTMLRNISNKDAAVRTA
>gid:334591  NMA0729  putative ABC transporter ATP-binding protein
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLM
NILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSL
TARDNVALPAVYMGAGGKERSARADKLLQDLGLASKEGNKPSELSGGQQQ
RVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIHKLHEAGHTVIMVT
HDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQ
FVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTS
SGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVV
IDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWS
PYTTVMHQITGESHTNSITVKIKDNANTQVAEKGLTDLLKARHGTEDFFM
NNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKE
IGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>gid:334720  NMA0763  putative ABC-transporter ATP-binding protein
MPSENTKGTTMTTHHVELRKVTKRFGAQKAVNQVDLVLKAGESVGLAGHN
GAGKSTIMKLILGLITPTEGEVMLLGERTGSKAGARLRSQIGYLPETVAL
HPSLTGIETLDFYAKLKKQPLTQNRGLLERVGISQAAHRRVGTYSKGMRQ
RLALAQALLGEPKVLLFDEPTTGLDPASRQMFYEVVRELNGRGATVLLST
HALAELDGHADRIIVD
>gid:334785  NMA0784  possible membrane protein
MKDSLMDFFDFFAQGKYKKIATEQGLDRKYFIFHYIVCNLSAISSFCLMK
VIHSYTILCLLIMIIGIAFGFILRNRVLSIVKNKQKFLSDMFPLEMPFFS
RVYKIPILARFLNRGMKWLYLQNFFCLVMICFSISLILNEERGWMPYFIC
YWFGLFYPANTYYVFLSRDYKRI
>gid:335693  NMA1022  putative transmembrane efflux protein
MLLDLNRFSFSVFLKEVRLLTALALPMLLAQVAQVGIGFVDTVMAGGAGK
EDLAAVALGSSAFATVYITFMGIMAALNPMIAQLYGAGKTDEVGETGRQG
IWFGLFLGVFGMVLMWAAITPFRNWLTLSDYVEGTMAQYMLFTSLAMPAA
MVHRALHAYASSLNRPRLIMLVSFAAFVLNVPLNYIFVYGKFGMPALGGA
GCGLATMAVFWFSALALWIYIAKENFFRPFGLTAKFGKPDWAVFKQIWKI
GAPIGLSYFLEASAFSFIVFLIAPFGEDYVAAQQVGISLSGILYMIPQSV
GSAGTVRIGFSLGRREFSRARYISGVSLVSGWMLAVITVLSLVLFRSPLV
SMYNNDPAVLSIAATVLLFAGLFQPADFTQCIASYALRGYKVTKVPMFIH
AAAFWGCGLLPGYLLAYRFDMGIYGFWTALIASLTIAAIALVWCLELCSR
EMVRSHKAV
>gid:335742  NMA1038  putative type I restriction-modification system protein
MMTEIQQRAQLHRQIWKIADEVRGAVDGWDFKQYVLGTLFYRFISENFTD
YMQAGDSSIDYAAMPDSIITPEIKDDAVKVKGYFIYPGQLFCNIAAEAHQ
NEELNTKLKEIFTAIESSASGYPSEQDIKGLFDDFDTTSSRLGSTVADKN
KRLAAVLKGVAELDFGSFEDHHIDLFGDAYEYLISNYAANAGKSGGEFFT
PQSVSKLIARLAVHGQEKVNKIYDPACGSGSLLLQAKKQFDEHIIEEGFF
GQEINHTTYNLARMNMFLHNVNYNKFHIELGDTLTNPKLKDSKPFDAVVS
NPPYSINWIGSGDPTLINDDRFAPAGVLAPKSKADFAFILHALNYLSGRG
RAAIVSFPGIFYRGGAEQKIRQYLVEGNYVETVIALAPNLFYGTGIAVNI
LVLSKHKDNTDIQFIDAGGFFKKETNNNVLTEEHIAEIVKLFADKADVPH
IAQNAAQQTVKDNGYNLAVSSYVEPEDTREIIDIKQLNAEISETVAKIER
LRREIDEVIAEIEA
>gid:336714  NMA1313  hypothetical protein NMA1313
MKSKEFLKSLAEYAAQLRQIIEAEVDGFDASPKAIAARRAKVFDPVGGYE
YFVNTYFPHYIRSPEKSELHAFLFSRLPEIIRSPKGENEAVGAPRGEGKS
TQVTQLFTLWCIVTGQKHYAVIVMDSIDQAYPMLEAIKAELEFNPRLKTD
FPEVCGQGRVWQAGTIVTANDVKVQVAGSGKKLRGLRHGPYRPDLTVLDD
IENDEQVRNPEQRDKLNAWLTKTVLPLGGVGQKYDVIYIGTILHYDSVLN
RTLNNPFWHGIKFKAMKRWPDRMDLWDRWEELFRNDGETVAEAFYLANKD
EMERGAQTSWAARGVLALMKIRARDGHATFDSEYQNDPVSGEDAPFAKSM
KFWNDLPSDLVYFGALDPSLGKAGASRDPSAIVIGGYQRSMGRLYVVEAQ
IKKRLPDLIIEDVICLHRQYRCKLWFVETVQFQEFLKDELVKRSAARGIP
VPARAVKPVSDKLLRIETLQPHMANGLILLNESQQTLIQQFRHFPKADHD
DGPDAVHMLWSGAVANCVPIEWQSPTDNDFDDEIKSKWSR
>gid:336969  NMA1402  putative ABC-transporter ATP-binding protein
MSELILKCEGVGKRYRDGGLDVLVLHGLDLEIRAGESTGIIGSSGSGKST
LLHILGGLDMPSEGRVLLMGEDLRTLNQRRLGDLRNRHLGFVYQFHHLLP
EFSALENVMMPLLIGKKSREEAAEAAMAMLEKVGLKHRSTHRAGELSGGE
RQRAAIARALVTQPKCLLADEPTGNLDRANARNVLDMMLELKTELGTGLV
VVTHDDELAGRFERVMVMKDGSLHPKQGANA
>gid:337193  NMA1466  putative type III restriction-modification system endonuclease protein
MSGFNYEKNQPHQMRAVSAVLGVFDGATPKYRAADENPELLFAAKQYADN
ILKVQSQNGIDGRFPDRSDDQNILDISMETGTGKTYTYTQTMFELHRWLG
VFKFIVVVPTLSIKAGTRQFLQSKALAEHFEQDFGGDYEGVRLKTYVVES
AKKNKGKKSNAPITIEQFVKAENKKEIHVLLINAGMVNSPSMTDTGDKAL
KDLFDNPVDALAAVRPFVIVDEPHKFPTRDSAKTWGNIKRLKPQYILRYG
ATFNDEYYNLLYRLTAVDAFNDGLVKGVRVFQEEMQGGMDAAVKLVSSDG
KEAKFELNEKDKKQTFKLAKGEDLAKIHPAVSDLKIDKMNKTVVVLSNGL
ELKTGAVINPYSYSQTVQDAMMQRAVAEHFKLERALLAERAPQPKIKPLT
LFFIDDIAGYRSGNELSGSLKDKFESWIHAEAARRLKTESDPFYRDYLQK
TLDDVSACHGGYFSKDNTDSDDRIEQEINEILHDKEKLLSLDNPRRFIFS
KWTLREGWDNPNVFQICKLRSSGSTTSKLQEVGRGLRLPVNELMARVRDV
PYKLNYFVDSSEKDFVKQLVGEINDNSFQEEISKKFTEELKQKILQKYPD
IKPLVLVNQLFSDGIIDDNENFAEDGYDKLKAAYPEAFPKGLDKGKVSNA
KDEGKDTIIMREGKYEELKALWELIHHKAVLQYKIKDEAEFVDLFTAYLR
ENAAKFPQAGIRTAVNEAYINNGLMLSRRIDSFEDEDFIRFNTMNYREFL
EKLAQTAKIRMQTLHQAFYRVRDELNIGDFLNMQTIAQIKNGFNRFLLHH
SFHKFELDYRLVGSKIHPTKFTDKDGKPRAVKKADLGRFEDTEHRPAAGY
LFDEIFYDSDIEHENVANNQIEGVTVFTKIPRNSIKIPVAGGGTYSPDFA
YIVKTKSGEILNFVIEAKGTDGAEDLRKSEERKIKHAEKLFAEISKEIKV
VFKTQFDGERIAELIGQNMPAVGHSENGY
>gid:337806  NMA1620  putative cytolysin secretion ABC transporter
MRSAVLFIYFFLLNIFLFQPAVIHIQSNYILFMSIVSAPLPALSALIILA
HYHGIAANPADIQHEFCTSAQSDLNETQWLLAAKSLGLKAKVVRQPIKRL
AMATLPALVWCDDGNHFILAKTDGGGEHAQYLIQDLTTNKSAVLSFAEFS
NRYSGKLILVASRASVLGSLAKFDFTWFIPAVIKYRRLFFEVLVVSVVLQ
LFALITPLFFQVVMDKVLVHRGFSTLDVVSVALLVVSLFEIVLGGLRTYL
FAHTTSRIDVELGARLFRHLLSLPLSYFEHRRVGDTVARVRELEQIRNFL
TGQALTSVLDLAFSFIFLAVMWYYSSTLTWVVLASLPAYAFWSAFISPIL
RTRLNDKFARNADNQSFLVESITAVGTVKAMAVEPQMTQRWDNQLAAYVA
SGFRVTKLAVVGQQGVQLIQKLVTVATLWIGARLVIESKLTVGQLIAFNM
LSGQVAAPVIRLAQLWQDFQQVGISVARLGDILNAPTENASSHLALPDIR
GEITFEHVDFRYKADGRLILQDLNLRIRAGEVLGIVGRSGSGKSTLTKLV
QRLYVPAQGRVLVDGNDLALAAPAWLRRQVGVVLQENVLLNRSIRDNIAL
TDTGMPLERIIEAAKLAGAHEFIMELPEGYGTVVGEQGAGLSGGQRQRIA
IARALITNPRILIFDEATSALDYESERAIMQNMQAICANRTVLIIAHRLS
TVKTAHRIIAMDKGRIVEAGTQQELLAKPNGYYRYLYDLQNG
>gid:338760  NMA1791  hypothetical protein
MEELPEYITRGVFDFMFGIEAKVRQIQEEANIQAAATIGRLHDALKEEGI
YEEHELRLFITRLLFLFFADDSAVFRRNYLFQDFLENCKEADTLGDKLNQ
LFEFLNTPDQKRSKTQSEKFKGFEYVNGGLFKERLRTFDFTAKQHRALID
CGNFDWRNISPEIFGTLFQSVMDAQERREAGAHYTEAANIDKVINGLFLE
NLRAEFEAVKALKRDKAKKLAAFYQKIQNLQFLDPACGCGNFLIVAYDRI
RALEDDIIAEALKDKADGLFDSPSVQCRLKQFHGIEIDEFAVLIARTAMW
LKNHQCNIRTQIRFDGEVACHTLPLEDAAEIIHANSLRTPWQAADYIFGN
PPFIGSTYQTKEQKNDLESICGHIKGYGLLDYVCNWYVKAAGIMAQHPQV
QTAFVSTNSICQGQQVEILWGSLLNQGIEIHFAHRTFQWTSQAAGKAAVH
CIIVGFRQKPPMPSEKTLYDYPDIKGEPEKHAVANINPYLIDAPDLIIAK
RSRPIHCEPDMVNGSKPTEGGNLILSTAEKDALIAAEPLAEQYIRPFIGA
DEFLNGKTRWCLWFHGVSDVKRNHDLKQMPQVQARIQAVKTMREASSDKQ
TQKDAATPWLFQKIRQPSDGNYLIIPSVSSESRRFIPIGYLSFETVVSNL
AFILPNATLYHFGILSSTMHNAFMRTVAGRLKSDYRYSNTVVYNNFPFPE
SCRLPSENDRPDPLRAAVEAAAQTVLDARGQYRREAQEAGLPEPTLAELY
APDAGYTALDKAHATLDKAVDKAYGYKTGKNTDDEAERVAFLFELYRKAA
AIA
>gid:338941  NMA1819  conserved hypothetical protein
MTEPTSRRRFLKTCTAAIGAGLLQACGTSATSVSPLPSFHSVVKARTVPL
QTPRRQSSDGNLLRVVASSGFAEDTNRVNTALTRLYNAGFTVTNQQAGSR
RFQRFAGTDSQRAADFQDVASGRVATPKVLMGLRGGYGAARILPHIDFAS
LGARMREHGTLFFGFSDVCAVQLALLAKGNMMSFAGPMAYSDFGKPAPGA
FTMDAFIKGATQNRLTVDVPYIQRADVETEGILWGGNLSVLASLAGTPYM
PDIDGGILFLEDVGEQPYRIERMLNTLYLSGILKKQRAIVFGNFRMEKIR
DVYDPSYDFSAVANHVSRTAKIPVLTGFPFGHIADKITFPLGAHARIRMN
GNSGYSVAFEGYPTLDASALTLDTLLPPPDLPIFPESGVADISE
>gid:339546  NMA2007  hypothetical protein
MESTLSLQANLYPRLTPAGAFYAVSSDAPSAGKTLLHSLLKADADEMVSS
EKLLTWADTADIDTALNLLYRLQKLEFLYGDENGHSDGINLSDEQLPLLM
EQLSGSGKALLVDRNGLYLANANFHHEAAEELGLLAAEVAQMEKKYRLLI
KNNLYINNNAWGVCDPSGQSELTFFPLYIGSTKFILVIGGIPDLGKEAFV
TLVRILYRRYSNRV
>gid:339961  NMA2077  putative integral membrane antobiotic resistance protein
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIDFHSNHKVFEITI
QLGAVLAVVFEYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLF
GKQIKEYLFNPLSVAVMLVLGGFFILWVEKRQSRAEPKIVDVDALRPIDA
LMIGVAQVFALVPGTSRSGSTIMGGMLWGIERKTATEFSFFLAVPMMVAA
TAYDVLKHYRFFTLHDVGLILIGFVAAFVSGLVAVKALLRFVSKKNYIPF
AYYRIVFGIAIIILWLSGWISWE
>gid:340582  NMA2223  putative ABC transporter
MLNKIFSWFESRIDPYPEAAPKTPEKGLWRFVWSSMAGVRKWIAALAALT
AGIGIMEALVFQFMGKIVEWLGKYAPAELFAEKGWELAAMAAMMVFSVAW
AFAASNVRLQTLQGVFPMRLRWNFHRLMLNQSLGFYQDEFAGRVSAKVMQ
TALALRDAVMTVADMVVYVSVYFITSGVILASLDSWLLLPFIGWIVGFAS
VMRLLIPKLGQTAAWQADARSLMTGRITDAYSNIATVKLFSHGAREAAYA
KQSMEEFMVTVRAQMRLATLLHSCSFIVNTSLTLSTAALGIWLWHNGQVG
VGAVATATAMALRVNGLSQYIMWESARLFENIGTVGDGMATLSKPHTILD
KPQALPLNVPQGAIKFEHVDFSYEAGKPLLNGFNLNIKPGEKVGLIGRSG
AGKSTIVNLLLRFYEPQSGTVLIDGQDISSVTQESLRAQIGLVTQDTSLL
HRSVRDNIIYGRPDATDAEMVSAAERAEAAGFIPDLSDAKGRRGYDAHVG
ERGVKLSGGQRQRIAIARVMLKDAPILLLDEATSALDSEVEAAIQESLDK
MMDGKTVIAIAHRLSTIAAMDRLVVLDKGRIIEEGTHAELLEKRGLYAKL
WAHQSGGFLSEHVEWQHD
>gid:335075  ampD  putative anhydro-N-acetylmuramyl-tripeptide amidase
MDNHAEAHWQNGWLQSIRHTPSPNFSPRETGETVSLIVLHNISLPPFEYG
TDAVEKLFANRLDPNGHPFFSLIHTLRVSSHFLIKRDGKTVQFVSCGDMA
YHAGVSSFRGREKCNAFSIGIELEGCDFEPFTEAQYRSLETLLEALCRRY
PVTAVTGHQDIAPGRKTDPGHFFDWRRIREKGFPVDRNAV
>gid:340313  emrA  multidrug resistance translocase
MKSGNSEPNLMDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFF
LWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLD
DDNDVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDL
RRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVS
LREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAP
LMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGF
SAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMT
VKVDTSAAGAPVSKTPGAALPEMESTDWSEVDRTVDEILGQSAP
>gid:339442  mtrD  probable drug efflux protein
MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLHATYP
GASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDE
NLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTE
EMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFAD
VGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILR
ANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMAT
AKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVF
VVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVI
GIVVDDAIVVVENVERIMADEGLPPKEATKKAMGQISGAVIGITAVLISV
FVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPK
GHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGV
FLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPE
IENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMM
MGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQ
KMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASA
LSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLST
IATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGG
GYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVIL
VIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNA
ILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAG
GASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMA
VKHAAEAGITGSDDSQH
>gid:335738  nmgI  putative type II restriction endonuclease
MPDFQRITIENIEYFIVDSIQNLRAEDSFIHRNNKLSVFGGNGEARKYVG
SYIDDSGRKLSTFFEYENWGITETKNGRRVEYPLIQKNCFFNKKNLQRYL
VDAKVEYHKQEQKYHHDISRFYDDYVLSINNLPTENIFFSIHDISDHLEN
SKGYRRGYIRSEDDIWSIWRKIVLSKISYLSILKLLPVKDIEDSEPLFYF
RIFLDYQFRSIVHPQLLSREKLEIPASEFNQFVEQEIIKQKSRKGQQKYR
KDVINHMPQCPFTLITDEILLRASHIKSYMVCITEKNEKEALDYLNGLAL
TPTYDWLFDQGYITFLDDGRLICGTRLSRYTWEKLNINPNAKNKMRIYPE
GREKYLEYHRKFVFQDNIDDFL